Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy. (Q53591512)
Jump to navigation
Jump to search
scientific article published in September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy. |
scientific article published in September 2006 |
Statements
Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy. (English)
Steven W Lane
Julie Crawford
Melita Kenealy
Gavin Cull
John F Seymour
H Miles Prince
Paula Marlton
Devinder Gill
Peter N Mollee
1 September 2006
47
9
1813-1817
1 reference
1 reference
1 reference
1 reference
1 reference